Product Details
Gadobutrol Injection, Single Dose Vial, 1 mmol/mL, 20 x 7.5 mL
Manufacturer: Fresenius Kabi
MFG#: 65219-0281-07
PID: 639333
20/BX
$837.88
In StockAdditional Information
| Product Name | Gadobutrol Injection, Single Dose Vial, 1 mmol/mL, 20 x 7.5 mL |
| Active Ingredient | Gadobutrol (Gadolinium-based contrast agent) |
| Drug Class | MRI Contrast Agent |
| Mechanism of Action | Enhances MRI images by altering the magnetic properties of tissues and blood vessels |
| Strength | 1 mmol/mL |
| Volume | 7.5 mL per vial, 20 vials per package |
| Dosage Form | Injectable Solution |
| Route of Administration | Intravenous (IV) |
| Side Effects | Headache, nausea, injection site reaction, dizziness, nephrogenic systemic fibrosis (in at-risk patients) |
| Precautions | Contraindicated in severe renal impairment, caution in patients with renal dysfunction or allergies to gadolinium |
| Storage | Store at room temperature (20–25°C); protect from light |
| Packaging | Single-dose vials, 7.5 mL each, 20 vials per box |
| Uses | MRI contrast agent for imaging of blood vessels, tissues, and organs |
Description
Gadobutrol Injection, 1 mmol/mL, 7.5 mL, is a gadolinium-based contrast agent used for magnetic resonance imaging (MRI) procedures. It is specifically designed to improve the visibility of blood vessels, tissues, and organs during MRI scans, enhancing diagnostic accuracy. The solution is administered intravenously and is effective for evaluating various conditions, including vascular, neurological, and musculoskeletal disorders.
Gadobutrol works by altering the magnetic properties of tissues during MRI, enabling enhanced image contrast. As a macrocyclic, stable contrast agent, it binds gadolinium ions in a way that reduces toxicity, minimizing the risk of nephrogenic systemic fibrosis (NSF) in patients with renal impairment. The 1 mmol/mL concentration provides high signal intensity for detailed imaging with a single dose.
Each vial contains 7.5 mL of the gadolinium-based solution, and the product is available in a package of 20 single-dose vials. This packaging ensures that the product is available for multiple procedures while maintaining sterility and preventing contamination. It is essential to administer the contrast under controlled conditions, with appropriate monitoring for adverse reactions.
Frequently Asked Questions (FAQs)
The cost of Gadobutrol Injection, Single Dose Vial, 1 mmol/mL, 20 x 7.5 mL is $$837.88
Gadobutrol Injection, Single Dose Vial, 1 mmol/mL, 20 x 7.5 mL is manufactured by Fresenius Kabi.
You can purchase Gadobutrol Injection, Single Dose Vial, 1 mmol/mL, 20 x 7.5 mL on our website at https://injx.pipelinemedical.com/product/detail/gadobutrol-injection-single-dose-vial-1-mmol-ml-20-x-7-5-ml-639333